Tagbo, Jimmy C.
HRN: 21-41-75 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2022
CEFTRIAXONE 1G (VIAL)
06/02/2022
06/08/2022
IV
1g
Q12h
T/c Acute Ap
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes